Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
April 27, 2015 10:05 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 27, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company") announced today that the Company received a decision to grant from the European Patent Office...
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
April 14, 2015 11:22 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 14, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company") announced today that an interference was declared by the Patent Trial and Appeal Board (PTAB)...
Forward Pharma Pre-IPO Investors Voluntarily Agree to Extend Lock-Up
April 09, 2015 17:31 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 9, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company" or "Forward") announced today an agreement among all of its pre-IPO shareholders to voluntarily...
Forward Pharma Reports Fourth Quarter and Year End 2014 Financial and Operational Results
March 25, 2015 06:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, March 25, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), today reported financial results for the fourth quarter and year ended December 31, 2014. Net loss for the...
Forward Pharma CFO to Present at the Future Leaders Conference on March 20th
March 16, 2015 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, March 16, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...
Forward Pharma CFO to Present at Two Upcoming Conferences in February
February 05, 2015 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...
Forward Pharma Receives Issue Notification for Erosion Matrix Patent in the U.S.
November 24, 2014 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) ("the Company") announced today that the Company received an issue notification from the United States Patent and...
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany
November 18, 2014 08:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 18, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) announced today that it has filed a lawsuit against Biogen Idec GmbH, Biogen Idec International GmbH and Biogen...
Forward Pharma A/S Announces Closing of Partial Exercise of Over-Allotment Option
November 14, 2014 16:10 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (the "Company") (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate...
Forward Pharma CFO to Present at Two Upcoming Conferences
November 14, 2014 06:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...